175 related articles for article (PubMed ID: 24855353)
41. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.
Hong J; Lu H; Meng X; Ryu JH; Hara Y; Yang CS
Cancer Res; 2002 Dec; 62(24):7241-6. PubMed ID: 12499265
[TBL] [Abstract][Full Text] [Related]
42. Novel Mucoadhesive Chitosomes as a Platform for Enhanced Oral Bioavailability of Cinnarizine.
Oransa HA; Boughdady MF; El-Sabbagh HM
Int J Nanomedicine; 2022; 17():5641-5660. PubMed ID: 36452306
[TBL] [Abstract][Full Text] [Related]
43. Tea polyphenols inhibit the transport of dietary phenolic acids mediated by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers.
Konishi Y; Kobayashi S; Shimizu M
J Agric Food Chem; 2003 Dec; 51(25):7296-302. PubMed ID: 14640574
[TBL] [Abstract][Full Text] [Related]
44. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
45. Nano-encapsulation of epigallocatechin gallate in the ferritin-chitosan double shells: Simulated digestion and absorption evaluation.
Yang R; Liu Y; Gao Y; Yang Z; Zhao S; Wang Y; Blanchard C; Zhou Z
Food Res Int; 2018 Jun; 108():1-7. PubMed ID: 29735037
[TBL] [Abstract][Full Text] [Related]
46. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
[TBL] [Abstract][Full Text] [Related]
47. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
48. Using Caffeine and Free Amino Acids To Enhance the Transepithelial Transport of Catechins in Caco-2 Cells.
Wang Y; Zuo Y; Deng S; Zhu F; Liu Q; Wang R; Li T; Cai H; Wan X; Xie Z; Xie Z; Li D
J Agric Food Chem; 2019 May; 67(19):5477-5485. PubMed ID: 30983343
[TBL] [Abstract][Full Text] [Related]
49. Development of an isocratic HPLC method for catechin quantification and its application to formulation studies.
Li D; Martini N; Wu Z; Wen J
Fitoterapia; 2012 Oct; 83(7):1267-74. PubMed ID: 22735602
[TBL] [Abstract][Full Text] [Related]
50. Bioactive dietary polyphenols decrease heme iron absorption by decreasing basolateral iron release in human intestinal Caco-2 cells.
Ma Q; Kim EY; Han O
J Nutr; 2010 Jun; 140(6):1117-21. PubMed ID: 20375262
[TBL] [Abstract][Full Text] [Related]
51. Transdermal delivery of tea catechins by electrically assisted methods.
Fang JY; Hung CF; Hwang TL; Wong WW
Skin Pharmacol Physiol; 2006; 19(1):28-37. PubMed ID: 16247247
[TBL] [Abstract][Full Text] [Related]
52. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Lambert JD; Kim DH; Zheng R; Yang CS
J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
[TBL] [Abstract][Full Text] [Related]
53. (-)-Epigallocatechin-3-gallate decreases colonic inflammation and permeability in a mouse model of colitis, but reduces macronutrient digestion and exacerbates weight loss.
Bitzer ZT; Elias RJ; Vijay-Kumar M; Lambert JD
Mol Nutr Food Res; 2016 Oct; 60(10):2267-2274. PubMed ID: 27218415
[TBL] [Abstract][Full Text] [Related]
54. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT.
Annaba F; Kumar P; Dudeja AK; Saksena S; Gill RK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G467-73. PubMed ID: 20056894
[TBL] [Abstract][Full Text] [Related]
55. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
[TBL] [Abstract][Full Text] [Related]
56. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage.
Minnelli C; Moretti P; Fulgenzi G; Mariani P; Laudadio E; Armeni T; Galeazzi R; Mobbili G
Int J Pharm; 2018 Dec; 552(1-2):225-234. PubMed ID: 30291957
[TBL] [Abstract][Full Text] [Related]
57. Effect of epigallocatechin gallate on drug transport mediated by the proton-coupled folate transporter.
Kissei M; Itoh T; Narawa T
Drug Metab Pharmacokinet; 2014; 29(5):367-72. PubMed ID: 24695276
[TBL] [Abstract][Full Text] [Related]
58. Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.
Guan M; Zhu QL; Liu Y; Bei YY; Gu ZL; Zhang XN; Zhang Q
Int J Nanomedicine; 2012; 7():1921-30. PubMed ID: 22605938
[TBL] [Abstract][Full Text] [Related]
59. Effects of Catechins and Their Related Compounds on Cellular Accumulation and Efflux Transport of Mitoxantrone in Caco-2 Cell Monolayers.
Sugihara N; Kuroda N; Watanabe F; Choshi T; Kamishikiryo J; Seo M
J Food Sci; 2017 May; 82(5):1224-1230. PubMed ID: 28346686
[TBL] [Abstract][Full Text] [Related]
60. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
